Literature DB >> 19563500

Thrombin generation and bleeding in haemophilia A.

K E Brummel-Ziedins1, M F Whelihan, M Gissel, K G Mann, G E Rivard.   

Abstract

Haemophilia A displays phenotypic heterogeneity with respect to clinical severity. The aim of this study was to determine if tissue factor (TF)-initiated thrombin generation profiles in whole blood in the presence of corn trypsin inhibitor (CTI) are predictive of bleeding risk in haemophilia A. We studied factor(F) VIII deficient individuals (11 mild, 4 moderate and 12 severe) with a well-characterized 5-year bleeding history that included haemarthrosis, soft tissue haematoma and annual FVIII concentrate usage. This clinical information was used to generate a bleeding score. The bleeding scores (range 0-32) were separated into three groups (bleeding score groupings: 0, 0 and < or = 9.6, >9.6), with the higher bleeding tendency having a higher score. Whole blood collected by phlebotomy and contact pathway suppressed by 100 microg mL(-1) CTI was stimulated to react by the addition of 5 pM TF. Reactions were quenched at 20 min by inhibitors. Thrombin generation, determined by enzyme-linked immunosorbent assay for thrombin-antithrombin was evaluated in terms of clot time (CT), maximum level (MaxL) and maximum rate (MaxR) and compared to the bleeding score. Data are shown as the mean+/-SD. MaxL was significantly different (P < 0.001) between the groups: 504 +/- 114, 315 +/- 117 and 194 +/- 91 nM; with higher thrombin concentrations in the groups with lower bleeding scores. MaxR was higher in the groups with a lower bleeding score; 97 +/- 51, 86 +/- 60 and 39 +/- 16 nM min(-1) (P = 0.09). No significant difference was detected in CT among the groups, 5.6 +/- 1.3, 4.7 +/- 0.7 and 5.6 +/- 1.3 min. Our empirical study in CTI-inhibited whole blood shows that the MaxL of thrombin generation appears to correlate with the bleeding phenotype of haemophilia A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563500      PMCID: PMC3395070          DOI: 10.1111/j.1365-2516.2009.01994.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  44 in total

1.  Platelet-dependent thrombography: a method for diagnostic laboratories.

Authors:  Yesim Dargaud; Roger Luddington; Trevor Baglin
Journal:  Br J Haematol       Date:  2006-08       Impact factor: 6.998

2.  A simple method for the preparation of homogeneous phospholipid vesicles.

Authors:  Y Barenholz; D Gibbes; B J Litman; J Goll; T E Thompson; R D Carlson
Journal:  Biochemistry       Date:  1977-06-14       Impact factor: 3.162

3.  An improved procedure for accurate assays of factor VIII.

Authors:  J Margolis
Journal:  Pathology       Date:  1979-04       Impact factor: 5.306

4.  An international collaborative assay of factor VIII clotting activity.

Authors:  T W Barrowcliffe; T B Kirkwood
Journal:  Thromb Haemost       Date:  1978-10-31       Impact factor: 5.249

5.  The resuscitative fluid you choose may potentiate bleeding.

Authors:  Kathleen Brummel-Ziedins; Matthew F Whelihan; Eduards G Ziedins; Kenneth G Mann
Journal:  J Trauma       Date:  2006-12

6.  Factor VIIa replacement therapy in factor VII deficiency.

Authors:  K Brummel Ziedins; G E Rivard; R L Pouliot; S Butenas; M Gissel; B Parhami-Seren; K G Mann
Journal:  J Thromb Haemost       Date:  2004-10       Impact factor: 5.824

Review 7.  Gene therapy for the hemophilias.

Authors:  T VandenDriessche; D Collen; M K L Chuah
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

Review 8.  The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability.

Authors:  H C Hemker; P Giesen; R AlDieri; V Regnault; E de Smed; R Wagenvoord; T Lecompte; S Béguin
Journal:  Pathophysiol Haemost Thromb       Date:  2002 Sep-Dec

9.  Thrombin generation: phenotypic quantitation.

Authors:  K E Brummel-Ziedins; R L Pouliot; K G Mann
Journal:  J Thromb Haemost       Date:  2004-02       Impact factor: 5.824

10.  Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.

Authors:  B Sørensen; J Ingerslev
Journal:  J Thromb Haemost       Date:  2004-01       Impact factor: 5.824

View more
  17 in total

1.  Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.

Authors:  Margaret V Ragni
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

2.  Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.

Authors:  J H Foley; M E Nesheim; G E Rivard; K E Brummel-Ziedins
Journal:  Haemophilia       Date:  2011-09-20       Impact factor: 4.287

3.  Measurement of procoagulant platelet subpopulations in whole blood: development of an assay for population-based studies.

Authors:  Beth A Bouchard; Aimee K Paradis; Kathleen E Brummel-Ziedins
Journal:  Thromb Res       Date:  2010-06-11       Impact factor: 3.944

Review 4.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

5.  Protein S: a Multifunctional Anticoagulant.

Authors:  A'drianne Dorsey; Vijaya Satish Pilli; Howard Fried; Rinku Majumder
Journal:  Biomed Res Clin Pract       Date:  2017-11-20

6.  Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.

Authors:  M V Ragni; J G Yabes; P F Fogarty; N C Josephson; C M Kessler; A T Neff; L Raffini; K Brummel-Ziedins; C G Moore
Journal:  Haemophilia       Date:  2016-12-11       Impact factor: 4.287

7.  Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.

Authors:  Y Buyue; T M Misenheimer; J P Sheehan
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

Review 8.  [Old and new anticoagulants. Antidotes and measures for acute hemorrhaging and urgent interventions].

Authors:  M Lancé; B Stessel; K Hamulyák; M A Marcus
Journal:  Anaesthesist       Date:  2010-01       Impact factor: 1.041

Review 9.  Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives.

Authors:  Guy Young; Benny Sørensen; Yesim Dargaud; Claude Negrier; Kathleen Brummel-Ziedins; Nigel S Key
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

Review 10.  Empirical and theoretical phenotypic discrimination.

Authors:  K E Brummel-Ziedins; T Orfeo; F R Rosendaal; A Undas; G E Rivard; S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.